Medical device executives and Ted Talk-ers love comparing the medtech industry to consumer electronics or aeronautics when making grand points about the market, but at Battelle cross-industry correlations speak to the core of the company’s engineering philosophy.
MassDevice Q&A
Animals in labs: PETA’s long history with the medtech industry
Animal rights activists have long raised concerns about some of the largest medical device companies, taking up minuscule stock holdings to gain access to shareholder meetings at a raft of medtech makers.
Silicon Valley in-depth: Tapping medtech’s Big Data with AliveCor CEO Euan Thomson
Big data and personalized medicine: Q&A with Definiens CEO Thomas Heydler
Definiens CEO Thomas Heydler is leading the charge to put his company at the forefront of personalized medicine, starting with a big data approach in order help treat patients.
The imaging software company, started by Nobel Physics prize winner Gerd Binnig, seeks to identify and analyze biomedical images in order to help doctors treat patients as early and efficiently as possible.
The making of an icon | Dr. Tom Fogarty’s love-hate relationship with the FDA
It’s been 50 years since Dr. Tom Fogarty invented the catheter-based treatment for blood clots that’s now the standard of care. At 80, it would be a cinch for Fogarty to retire to his California vineyard and bask in the reflected glory of his accomplishments.
But Fogarty, a serial entrepreneur with more than 30 medical device startups under his belt, told MassDevice.com recently that he has no plans to slow down until he’s 6 feet under.
The making of an icon | Dr. Tom Fogarty’s ‘Fog Shop’
It’s been 50 years since Dr. Tom Fogarty invented the catheter-based treatment for blood clots that’s now the standard of care. At 80, it would be a cinch for Fogarty to retire to his California vineyard and bask in the reflected glory of his accomplishments.
The making of an icon | Dr. Tom Fogarty’s obsession with innovation
It’s been 50 years since Dr. Tom Fogarty invented the catheter-based treatment for blood clots that’s now the standard of care. At 80, it would be a cinch for Fogarty to retire to his California vineyard and bask in the reflected glory of his accomplishments.
DNA sequencing in a handheld laboratory – Q&A with QuantuMDx founder Jonathan O’Halloran
QuantuMDx came from humble beginnings, and it’s still rather humble now, but the company has a grand vision for the future. With re-imagined diagnostic technology and a burgeoning gene sequencing revolution, QuantuMDx hopes 1 day to see a diagnostic lab in every medicine cabinet and cheap testing that can reach every under-served population.
Breathing easier with SinuSys | MassDevice Q&A
SinuSys executives Thomas Schreck and Dr. Jerome Hester had a very different relationship just 3 years ago. Schreck, a serial entrepreneur now on his 3rd venture, was Hester’s patient up until a fateful lunch meeting in Menlo Park, Calif., that led to the founding of SinuSys.
The pair are now busy with the commercial phase of their joint venture, having earlier this year won FDA clearance for the Vent-Os sinus dilation system.
Preventing plagiocephaly: A conversation with Invictus Medical’s Tom Roberts
For Tom Roberts, good healthcare starts with prevention.
It’s a mantra the CEO of San Antonio, Texas-based startup Invictus Medical holds close to his heart.
In 2010, interrupting a 25-year medical device career that had taken him to Boehringer Manheim, Roche Diagnostics and Kinetic Concepts Inc., Roberts took a leave of absence in 2010 to serve as a caretaker for his ailing mother.
A problem for all of us: Philips Healthcare on joining the Patient Safety Movement
Philips Healthcare (NYSE:PHG) this month joined a coalition of medtech companies and healthcare stakeholders in vowing to eliminate preventable hospital deaths by the year 2020.